Bloomberg -- The U.S. Supreme Court will consider whether generic-drug makers can be sued for not warning patients about the risk of dangerous side effects, agreeing to hear arguments from units of Mylan Inc. and Teva Pharmaceutical Industries Ltd. The justices today said they will review lawsuits by two women who say they contracted a severe neurological disorder as a result of long-term use of metoclopramide, a drug used to treat stomach conditions. The women say the drug carried inadequate safety warnings.
